Applied Competitors

Delisted . USA . 
Stock . Applied Molecular Transport
AMTIDelisted Stock  USD 0.33  0.00  0.00%   
Applied Molecular competes with Aileron Therapeutics, Bio Path, Benitec Biopharma, Aerovate Therapeutics, and Adagene; as well as few others. The company conducts business under Biotechnology sector and is part of Health Care industry. Analyzing Applied Molecular competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Applied Molecular to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Applied Molecular competition on your existing holdings.
  
Specify up to 10 symbols:
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Applied Molecular's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.330.330.33
Details
Intrinsic
Valuation
LowRealHigh
0.270.270.36
Details
Naive
Forecast
LowNextHigh
0.340.340.34
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.250.310.36
Details

Applied Molecular Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Applied Molecular and its competitors represents the degree of relationship between the price movements of corresponding delisted stocks. A correlation of about +1.0 implies that the price of Applied and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Applied Molecular does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
AVTE
+ 0.85
CBIO
ACRV
+ 0.78
ADAG
AVTE
+ 0.7
BNTC
BNTC
+ 0.57
ALRN
BNTC
+ 0.55
CBIO
RZLT
+ 0.52
AVTE
  
High negative correlations   
BPTH
- 0.53
CBIO
AVTE
- 0.42
BPTH
ANTX
- 0.32
ALRN
ANTX
- 0.27
BPTH
ACRV
- 0.26
AVTE
ACRV
- 0.26
CBIO

Risk-Adjusted Indicators

There is a big difference between Applied Stock performing well and Applied Molecular Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Applied Molecular's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
All Fundamental Data

Applied Molecular Competitive Analysis

The better you understand Applied Molecular competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Applied Molecular's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Applied Molecular's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
AMTI CBIO ALRN BPTH BNTC AVTE ADAG ACRV RZLT ANTX
 0.00 
 0.33 
Applied
 4.65 
 0.41 
Catalyst
 4.07 
 2.56 
Aileron
 2.44 
 0.80 
Bio
 2.96 
 9.85 
Benitec
 0.75 
 2.68 
Aerovate
 2.20 
 2.22 
Adagene
 2.65 
 7.35 
Acrivon
 1.44 
 4.79 
Rezolute
 3.73 
 1.39 
AN2
Market Volatility
(90 Days Market Risk)
Very steady
Very steady
Slightly risky
Abnormally volatile
Slightly risky
Somewhat reliable
Dangerous
Somewhat reliable
Moderately volatile
Slightly risky
Market Performance
(90 Days Performance)
Very Weak
Very Weak
Insignificant
Very Weak
Insignificant
Good
Very Weak
Very Weak
Weak
OK
Odds of Financial Distress
(Probability Of Bankruptcy)
Dangerous
Dangerous
About Average
Very High
About Average
Low
Average
Low
Low
Average
Current Valuation
(Equity Enterprise Value)
Over Valued
Over Valued
Under Valued
Over Valued
Over Valued
Under Valued
Over Valued
Under Valued
Under Valued
Under Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Strong Buy
Buy
Strong Buy
Hold
Buy
Strong Buy
Strong Buy
Buy
Trade Advice
(90 Days Macroaxis Advice)
Not Rated
Not Rated
Strong Sell
Strong Sell
Strong Sell
Cautious Hold
Strong Sell
Sell
Sell
Strong Buy
Current Ratio
6.25
18.86
6.51
15.57
1.9
40.85
3.1
N/A
61.78
28.17
Net Asset
107.45 M
28.44 M
106.01 M
3.22 M
52.21 M
127.42 M
115.73 M
138.26 M
132.74 M
138.74 M
Profit Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
EBITDA
(127.22 M)
(52.15 M)
(15.61 M)
(15.76 M)
(22.49 M)
(81.31 M)
(14.95 M)
(59.85 M)
(68.42 M)
4.9 M
Current Valuation
(5.88 M)
51.03 M
38.2 M
2.93 M
161.05 M
(10.81 M)
23.4 M
45.41 M
175.41 M
(53.71 M)
Price To Book
0.7
0.53
1.1
2.34
3.56
0.96
1.74
1.16
2.48
0.47
Operating Margin
N/A
N/A
N/A
N/A
N/A
N/A
-45.35
N/A
N/A
N/A
Retained Earnings
(365.97 M)
(410.94 M)
(288.52 M)
(107.61 M)
(190.26 M)
(163.42 M)
(277.75 M)
(116.42 M)
(329.44 M)
(154.46 M)
Current Asset
N/A
68.7 M
3.43 M
9.59 M
19.38 M
N/A
N/A
N/A
N/A
N/A
Beta
2.29
1.29
2.34
0.22
0.88
1.0
0.58
N/A
1.19
-0.22
Number Of Employees
13
7
15
10
16
51
174
58
59
41
Shares Outstanding
41.85 M
37.97 M
21.67 M
4.31 M
19.82 M
28.87 M
44.27 M
31.14 M
57.94 M
29.88 M
Cash Flow From Operations
(93.9 M)
(33.1 M)
(19.81 M)
(11.54 M)
(19.4 M)
(56.78 M)
(28.45 M)
(42.64 M)
(57.37 M)
(53.29 M)
Annual Yield
N/A
7.93
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Debt
36.12 M
38 K
48 K
113 K
284 K
675 K
22.31 M
4.64 M
2.23 M
14.04 M
Return On Equity
-1.58
-2.69
-0.44
-3.66
-0.92
-0.82
-0.46
-0.38
-0.58
-0.69
Z Score
-7.95
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Return On Asset
-0.51
-0.38
-0.26
-1.4
-0.5
-0.49
-0.2
-0.24
-0.34
-0.43
Number Of Shares Shorted
292.87 K
34.05 K
233.27 K
77.76 K
56.89 K
549.75 K
12.29 K
1.08 M
1.12 M
133.57 K
Book Value Per Share
0.4
-0.78
1.41
0.71
4.68
2.79
1.28
5.38
2.27
4.19
Current Liabilities
N/A
37.76 M
459 K
937 K
1.03 M
N/A
N/A
N/A
N/A
N/A
Total Asset
107.45 M
28.44 M
106.01 M
3.22 M
52.21 M
127.42 M
115.73 M
138.26 M
132.74 M
138.74 M
Debt To Equity
0.38
0.017
0.003
0.013
0.28
0.008
0.15
N/A
0.001
N/A
Short Ratio
0.96
0.19
3.47
0.03
1.35
1.11
0.33
15.38
3.16
0.82
Target Price
1.0
16.0
13.0
12.0
24.0
2.33
10.54
21.56
13.0
2.67
Shares Owned By Institutions
37.2
8.75
28.47
1.08
46.12
99.98
25.54
75.97
64.24
52.31
Market Capitalization
11.01 M
19.37 M
55.46 M
3.46 M
215.39 M
77.38 M
108.46 M
228.85 M
277.55 M
41.53 M
Price To Earnings To Growth
-0.01
0.02
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Price To Earning
N/A
-0.34
-0.31
-6.21
-5.1
0.64
N/A
N/A
N/A
3.96
Price To Sales
N/A
4.82
N/A
N/A
2770.13
N/A
120.48
N/A
N/A
N/A
Net Income
(126.33 M)
(8.24 M)
(15.73 M)
(16.08 M)
(21.75 M)
(75.52 M)
(18.95 M)
(60.39 M)
(68.46 M)
(64.73 M)
Earnings Per Share
-1.89
-1.5
-2.88
-8.34
-5.51
-2.99
-0.72
-2.66
-1.27
-1.99
Shares Owned By Insiders
21.35
27.73
0.6
N/A
4.38
0.018
10.65
22.38
13.74
21.63
Revenue
N/A
794 K
N/A
N/A
216 K
N/A
18.11 M
N/A
N/A
N/A
Working Capital
48.93 M
11.38 M
13.88 M
1.14 M
46.75 M
106.59 M
81.99 M
116.39 M
119.05 M
96.46 M
Cash And Equivalents
95.83 M
75.39 M
32.38 M
17.02 M
4.06 M
151.99 M
168.04 M
N/A
150.41 M
113.39 M
Cash Per Share
2.46
2.39
0.36
2.38
0.5
6.22
3.87
N/A
3.87
5.84
Gross Profit
(42.08 M)
(64.91 M)
(17.01 M)
N/A
75 K
N/A
10.18 M
N/A
N/A
N/A
Day Typical Price
0.32
0.42
2.57
0.79
9.95
2.68
2.25
7.35
4.82
1.4
Accumulation Distribution
0.0606
0.0909
0.0566
0.05
0.0459
0.033
0.0684
0.0478
0.0444
0.069
Market Facilitation Index
0.02
0.04
0.15
0.04
0.47
0.09
0.16
0.36
0.22
0.1
Daily Balance Of Power
N/A
(0.50)
0.6667
(0.50)
(0.64)
0.2222
(0.31)
0.5278
(0.32)
0.5
Period Momentum Indicator
N/A
(0.02)
0.1
(0.02)
(0.30)
0.02
(0.05)
0.19
(0.07)
0.05
Rate Of Daily Change
1.0
0.95
1.04
0.98
0.97
1.01
0.98
1.03
0.99
1.04
Day Median Price
0.32
0.42
2.58
0.78
10.0
2.69
2.26
7.35
4.84
1.4
Price Action Indicator
0.01
(0.02)
0.035
0.01
(0.30)
0.005
(0.07)
0.095
(0.09)
0.015
Relative Strength Index
53.64
61.55
39.62
42.34
48.69
61.94
42.74
46.89
44.95
70.55
Coefficient Of Variation
3673.58
589.1
2554.09
(1,755)
2354.8
596.23
(2,341)
(1,437)
3785.46
875.64
Mean Deviation
5.08
4.25
4.17
4.02
3.27
2.53
4.39
2.88
2.75
1.95
Jensen Alpha
(0.09)
1.02
0.19
(0.39)
0.1699
0.6364
(0.31)
(0.52)
(0.08)
0.3092
Total Risk Alpha
(0.93)
0.0604
(0.72)
(1.46)
(0.55)
0.0271
(1.24)
(0.97)
(0.56)
(0.17)
Sortino Ratio
0.0081
0.1239
0.0209
N/A
0.019
0.1843
N/A
N/A
(0.01)
0.0984
Downside Variance
56.92
46.59
24.27
N/A
13.08
6.76
N/A
N/A
11.08
8.38
Standard Deviation
7.03
5.75
5.96
6.75
4.69
3.63
6.15
4.21
4.19
3.64
Kurtosis
2.32
2.35
6.48
19.23
4.55
3.84
2.05
1.62
10.77
21.5
Potential Upside
11.11
9.76
8.06
6.67
7.89
5.58
8.13
7.66
6.8
3.73
Treynor Ratio
0.0817
(2.37)
0.8054
5.46
1.18
(1.95)
(0.83)
(0.17)
0.0674
0.508
Maximum Drawdown
36.6
38.47
41.47
51.22
29.78
19.11
37.93
22.84
30.01
28.03
Variance
49.46
33.08
35.54
45.58
21.99
13.2
37.8
17.75
17.57
13.23
Market Risk Adjusted Performance
0.0917
(2.36)
0.8154
5.47
1.19
(1.94)
(0.82)
(0.16)
0.0774
0.518
Risk Adjusted Performance
0.0297
0.1384
0.0386
(0.03)
0.0408
0.1361
(0.02)
(0.05)
0.0284
0.0952
Skewness
0.7979
0.1491
1.48
3.11
1.5
1.47
(0.58)
(0.18)
2.24
3.63
Semi Deviation
5.7
4.45
4.69
N/A
3.49
2.13
N/A
N/A
3.11
1.86
Information Ratio
0.0087
0.1471
0.0173
(0.08)
0.0147
0.1318
(0.06)
(0.10)
(0)
0.0783
Value At Risk
(10.34)
(8.33)
(7.99)
(8.08)
(4.52)
(3.86)
(9.52)
(7.65)
(5.54)
(3.42)
Expected Short fall
(6.89)
(6.17)
(4.98)
N/A
(3.92)
(3.38)
N/A
N/A
(3.13)
(3.09)
Downside Deviation
7.54
6.83
4.93
N/A
3.62
2.6
N/A
N/A
3.33
2.89
Semi Variance
32.54
19.84
22.01
N/A
12.15
4.55
N/A
N/A
9.7
3.46

Applied Molecular Competition Performance Charts

Five steps to successful analysis of Applied Molecular Competition

Applied Molecular's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Applied Molecular in relation to its competition. Applied Molecular's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Applied Molecular in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Applied Molecular's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Applied Molecular, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Applied Molecular position

In addition to having Applied Molecular in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Russia On Wall Street Thematic Idea Now

Russia On Wall Street
Russia On Wall Street Theme
Cross-sector and cross-instrument bundle of publicly traded Russian entities that are expected to be listed on USA exchanges or over the counter. The Russia On Wall Street theme has 23 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Russia On Wall Street Theme or any other thematic opportunities.
View All  Next Launch
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.

Other Consideration for investing in Applied Stock

If you are still planning to invest in Applied Molecular check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Applied Molecular's history and understand the potential risks before investing.
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Stocks Directory
Find actively traded stocks across global markets
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY